Ekso Bionics Holdings Management
Management criteria checks 4/4
Ekso Bionics Holdings' CEO is Scott Davis, appointed in Dec 2022, has a tenure of 2.08 years. total yearly compensation is $637.02K, comprised of 58.9% salary and 41.1% bonuses, including company stock and options. directly owns 0.47% of the company’s shares, worth $86.26K. The average tenure of the management team and the board of directors is 2.8 years and 3.6 years respectively.
Key information
Scott Davis
Chief executive officer
US$637.0k
Total compensation
| CEO salary percentage | 58.9% |
| CEO tenure | 2.1yrs |
| CEO ownership | 0.5% |
| Management average tenure | 2.8yrs |
| Board average tenure | 3.6yrs |
Recent management updates
Recent updates
Take Care Before Jumping Onto Ekso Bionics Holdings, Inc. (NASDAQ:EKSO) Even Though It's 27% Cheaper
Nov 12
Investors Give Ekso Bionics Holdings, Inc. (NASDAQ:EKSO) Shares A 26% Hiding
Aug 29Many Still Looking Away From Ekso Bionics Holdings, Inc. (NASDAQ:EKSO)
Jul 13Ekso Bionics Holdings, Inc. (NASDAQ:EKSO) Released Earnings Last Week And Analysts Lifted Their Price Target To US$10.00
May 02Market Still Lacking Some Conviction On Ekso Bionics Holdings, Inc. (NASDAQ:EKSO)
Dec 20Sentiment Still Eluding Ekso Bionics Holdings, Inc. (NASDAQ:EKSO)
Jun 19Ekso Bionics: Fragile Opportunity
Aug 24Is Ekso Bionics Holdings (NASDAQ:EKSO) A Risky Investment?
Jun 14Health Check: How Prudently Does Ekso Bionics Holdings (NASDAQ:EKSO) Use Debt?
Feb 05Ekso Bionics: Expecting More Of The Same
Jan 25Is Ekso Bionics Holdings (NASDAQ:EKSO) Weighed On By Its Debt Load?
Sep 22CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | -US$11m |
| Jun 30 2024 | n/a | n/a | -US$12m |
| Mar 31 2024 | n/a | n/a | -US$14m |
| Dec 31 2023 | US$637k | US$375k | -US$15m |
| Sep 30 2023 | n/a | n/a | -US$15m |
| Jun 30 2023 | n/a | n/a | -US$16m |
| Mar 31 2023 | n/a | n/a | -US$15m |
| Dec 31 2022 | US$1m | US$370k | -US$15m |
Compensation vs Market: Scott's total compensation ($USD637.02K) is about average for companies of similar size in the US market ($USD641.95K).
Compensation vs Earnings: Scott's compensation has been consistent with company performance over the past year.
CEO
Scott Davis (54 yo)
2.1yrs
Tenure
US$637,020
Compensation
Mr. Scott G. Davis serves as Chief Executive Officer of Ekso Bionics Holdings, Inc. since December 04, 2022 and serves as Director since December 08, 2022, and also served as its President & Chief Operatin...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Director | 2.1yrs | US$637.02k | 0.47% $ 86.3k | |
| Chief Financial Officer | 2.6yrs | US$726.08k | 0.20% $ 37.4k | |
| Chief Operating Officer | 2yrs | US$710.24k | 0.22% $ 40.2k | |
| Global Director of Marketing & Strategic Growth | 4yrs | no data | no data | |
| Human Resources Director | 2.8yrs | no data | no data | |
| President of APAC | 7yrs | no data | no data | |
| Senior VP & GM of EMEA | 3yrs | no data | no data | |
| Principal Controls Engineer | no data | no data | no data |
2.8yrs
Average Tenure
Experienced Management: EKSO's management team is considered experienced (2.8 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Director | 2.1yrs | US$637.02k | 0.47% $ 86.3k | |
| Member of Advisory Council | no data | no data | no data | |
| Member of Advisory Council | no data | no data | no data | |
| Independent Director | 4.1yrs | US$147.01k | 0.65% $ 118.1k | |
| Lead Independent Director | 3.1yrs | US$158.13k | 0.67% $ 122.8k | |
| Member of Advisory Council | no data | no data | no data | |
| Member of Advisory Council | no data | no data | no data | |
| Member of Advisory Council | no data | US$72.21k | no data | |
| Member of Advisory Council | no data | no data | no data | |
| Member of Advisory Council | no data | no data | no data | |
| Member of Advisory Council | no data | no data | no data | |
| Independent Director | 6.8yrs | US$143.10k | 0.36% $ 65.7k |
3.6yrs
Average Tenure
54.5yo
Average Age
Experienced Board: EKSO's board of directors are considered experienced (3.6 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/01/08 01:26 |
| End of Day Share Price | 2025/01/08 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Ekso Bionics Holdings, Inc. is covered by 11 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Gregory Chodaczek | B. Riley Securities, Inc. |
| Craig Bijou | Cantor Fitzgerald & Co. |
| Gregory Chodaczek | CRT Capital Group |